Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficiency) Equity - Offerings of Common Stock and Warrants (Details)

v3.24.1.1.u2
Stockholders' (Deficiency) Equity - Offerings of Common Stock and Warrants (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 04, 2019
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2022
Mar. 31, 2021
Stockholders' (Deficiency) Equity                  
Registered Direct Offering, common stock, aggregate shares offered, shares (in shares) 580,000                
Registered Direct Offering, common stock, aggregate shares offered, share price (in dollars per share) $ 5.00                
Proceeds from issuance of common stock and warrants, Registered Direct Offering $ 5,100                
Proceeds from issuance of common stock and warrants, net of offering costs $ 4,600 $ 11,159 $ 1,376 $ 11,186 $ 1,392 $ 11,194 $ 1,402 $ 11,271 $ 15,905